1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hormone Refractory Prostate Cancer Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Chemotherapy 1.2.3 Hormonal Therapy 1.2.4 Immunotherapy 1.2.5 Radiation Therapy 1.3 Market by Application 1.3.1 Global Hormone Refractory Prostate Cancer Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Ambulatory Surgical Centers 1.3.4 Specialty Clinics 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hormone Refractory Prostate Cancer Market Perspective (2017-2028) 2.2 Hormone Refractory Prostate Cancer Growth Trends by Region 2.2.1 Hormone Refractory Prostate Cancer Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Hormone Refractory Prostate Cancer Historic Market Size by Region (2017-2022) 2.2.3 Hormone Refractory Prostate Cancer Forecasted Market Size by Region (2023-2028) 2.3 Hormone Refractory Prostate Cancer Market Dynamics 2.3.1 Hormone Refractory Prostate Cancer Industry Trends 2.3.2 Hormone Refractory Prostate Cancer Market Drivers 2.3.3 Hormone Refractory Prostate Cancer Market Challenges 2.3.4 Hormone Refractory Prostate Cancer Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hormone Refractory Prostate Cancer Players by Revenue 3.1.1 Global Top Hormone Refractory Prostate Cancer Players by Revenue (2017-2022) 3.1.2 Global Hormone Refractory Prostate Cancer Revenue Market Share by Players (2017-2022) 3.2 Global Hormone Refractory Prostate Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Hormone Refractory Prostate Cancer Revenue 3.4 Global Hormone Refractory Prostate Cancer Market Concentration Ratio 3.4.1 Global Hormone Refractory Prostate Cancer Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hormone Refractory Prostate Cancer Revenue in 2021 3.5 Hormone Refractory Prostate Cancer Key Players Head office and Area Served 3.6 Key Players Hormone Refractory Prostate Cancer Product Solution and Service 3.7 Date of Enter into Hormone Refractory Prostate Cancer Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hormone Refractory Prostate Cancer Breakdown Data by Type 4.1 Global Hormone Refractory Prostate Cancer Historic Market Size by Type (2017-2022) 4.2 Global Hormone Refractory Prostate Cancer Forecasted Market Size by Type (2023-2028) 5 Hormone Refractory Prostate Cancer Breakdown Data by Application 5.1 Global Hormone Refractory Prostate Cancer Historic Market Size by Application (2017-2022) 5.2 Global Hormone Refractory Prostate Cancer Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Hormone Refractory Prostate Cancer Market Size (2017-2028) 6.2 North America Hormone Refractory Prostate Cancer Market Size by Country (2017-2022) 6.3 North America Hormone Refractory Prostate Cancer Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Hormone Refractory Prostate Cancer Market Size (2017-2028) 7.2 Europe Hormone Refractory Prostate Cancer Market Size by Country (2017-2022) 7.3 Europe Hormone Refractory Prostate Cancer Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Hormone Refractory Prostate Cancer Market Size (2017-2028) 8.2 Asia-Pacific Hormone Refractory Prostate Cancer Market Size by Country (2017-2022) 8.3 Asia-Pacific Hormone Refractory Prostate Cancer Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Hormone Refractory Prostate Cancer Market Size (2017-2028) 9.2 Latin America Hormone Refractory Prostate Cancer Market Size by Country (2017-2022) 9.3 Latin America Hormone Refractory Prostate Cancer Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hormone Refractory Prostate Cancer Market Size (2017-2028) 10.2 Middle East & Africa Hormone Refractory Prostate Cancer Market Size by Country (2017-2022) 10.3 Middle East & Africa Hormone Refractory Prostate Cancer Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Astellas Inc 11.1.1 Astellas Inc Company Detail 11.1.2 Astellas Inc Business Overview 11.1.3 Astellas Inc Hormone Refractory Prostate Cancer Introduction 11.1.4 Astellas Inc Revenue in Hormone Refractory Prostate Cancer Business (2017-2022) 11.1.5 Astellas Inc Recent Development 11.2 Sanofi S.A 11.2.1 Sanofi S.A Company Detail 11.2.2 Sanofi S.A Business Overview 11.2.3 Sanofi S.A Hormone Refractory Prostate Cancer Introduction 11.2.4 Sanofi S.A Revenue in Hormone Refractory Prostate Cancer Business (2017-2022) 11.2.5 Sanofi S.A Recent Development 11.3 Dendreon Corporation, Bayer AG 11.3.1 Dendreon Corporation, Bayer AG Company Detail 11.3.2 Dendreon Corporation, Bayer AG Business Overview 11.3.3 Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer Introduction 11.3.4 Dendreon Corporation, Bayer AG Revenue in Hormone Refractory Prostate Cancer Business (2017-2022) 11.3.5 Dendreon Corporation, Bayer AG Recent Development 11.4 Johnson & Johnson 11.4.1 Johnson & Johnson Company Detail 11.4.2 Johnson & Johnson Business Overview 11.4.3 Johnson & Johnson Hormone Refractory Prostate Cancer Introduction 11.4.4 Johnson & Johnson Revenue in Hormone Refractory Prostate Cancer Business (2017-2022) 11.4.5 Johnson & Johnson Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hormone Refractory Prostate Cancer Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Chemotherapy Table 3. Key Players of Hormonal Therapy Table 4. Key Players of Immunotherapy Table 5. Key Players of Radiation Therapy Table 6. Global Hormone Refractory Prostate Cancer Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Hormone Refractory Prostate Cancer Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Hormone Refractory Prostate Cancer Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Hormone Refractory Prostate Cancer Market Share by Region (2017-2022) Table 10. Global Hormone Refractory Prostate Cancer Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Hormone Refractory Prostate Cancer Market Share by Region (2023-2028) Table 12. Hormone Refractory Prostate Cancer Market Trends Table 13. Hormone Refractory Prostate Cancer Market Drivers Table 14. Hormone Refractory Prostate Cancer Market Challenges Table 15. Hormone Refractory Prostate Cancer Market Restraints Table 16. Global Hormone Refractory Prostate Cancer Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Hormone Refractory Prostate Cancer Market Share by Players (2017-2022) Table 18. Global Top Hormone Refractory Prostate Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormone Refractory Prostate Cancer as of 2021) Table 19. Ranking of Global Top Hormone Refractory Prostate Cancer Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Hormone Refractory Prostate Cancer Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Hormone Refractory Prostate Cancer Product Solution and Service Table 23. Date of Enter into Hormone Refractory Prostate Cancer Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Hormone Refractory Prostate Cancer Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Hormone Refractory Prostate Cancer Revenue Market Share by Type (2017-2022) Table 27. Global Hormone Refractory Prostate Cancer Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Hormone Refractory Prostate Cancer Revenue Market Share by Type (2023-2028) Table 29. Global Hormone Refractory Prostate Cancer Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Hormone Refractory Prostate Cancer Revenue Market Share by Application (2017-2022) Table 31. Global Hormone Refractory Prostate Cancer Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Hormone Refractory Prostate Cancer Revenue Market Share by Application (2023-2028) Table 33. North America Hormone Refractory Prostate Cancer Market Size by Country (2017-2022) & (US$ Million) Table 34. North America Hormone Refractory Prostate Cancer Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe Hormone Refractory Prostate Cancer Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe Hormone Refractory Prostate Cancer Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific Hormone Refractory Prostate Cancer Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific Hormone Refractory Prostate Cancer Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America Hormone Refractory Prostate Cancer Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America Hormone Refractory Prostate Cancer Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa Hormone Refractory Prostate Cancer Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa Hormone Refractory Prostate Cancer Market Size by Country (2023-2028) & (US$ Million) Table 43. Astellas Inc Company Detail Table 44. Astellas Inc Business Overview Table 45. Astellas Inc Hormone Refractory Prostate Cancer Product Table 46. Astellas Inc Revenue in Hormone Refractory Prostate Cancer Business (2017-2022) & (US$ Million) Table 47. Astellas Inc Recent Development Table 48. Sanofi S.A Company Detail Table 49. Sanofi S.A Business Overview Table 50. Sanofi S.A Hormone Refractory Prostate Cancer Product Table 51. Sanofi S.A Revenue in Hormone Refractory Prostate Cancer Business (2017-2022) & (US$ Million) Table 52. Sanofi S.A Recent Development Table 53. Dendreon Corporation, Bayer AG Company Detail Table 54. Dendreon Corporation, Bayer AG Business Overview Table 55. Dendreon Corporation, Bayer AG Hormone Refractory Prostate Cancer Product Table 56. Dendreon Corporation, Bayer AG Revenue in Hormone Refractory Prostate Cancer Business (2017-2022) & (US$ Million) Table 57. Dendreon Corporation, Bayer AG Recent Development Table 58. Johnson & Johnson Company Detail Table 59. Johnson & Johnson Business Overview Table 60. Johnson & Johnson Hormone Refractory Prostate Cancer Product Table 61. Johnson & Johnson Revenue in Hormone Refractory Prostate Cancer Business (2017-2022) & (US$ Million) Table 62. Johnson & Johnson Recent Development Table 63. Research Programs/Design for This Report Table 64. Key Data Information from Secondary Sources Table 65. Key Data Information from Primary Sources List of Figures Figure 1. Global Hormone Refractory Prostate Cancer Market Share by Type: 2021 VS 2028 Figure 2. Chemotherapy Features Figure 3. Hormonal Therapy Features Figure 4. Immunotherapy Features Figure 5. Radiation Therapy Features Figure 6. Global Hormone Refractory Prostate Cancer Market Share by Application in 2021 & 2028 Figure 7. Hospitals Case Studies Figure 8. Ambulatory Surgical Centers Case Studies Figure 9. Specialty Clinics Case Studies Figure 10. Hormone Refractory Prostate Cancer Report Years Considered Figure 11. Global Hormone Refractory Prostate Cancer Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Hormone Refractory Prostate Cancer Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Hormone Refractory Prostate Cancer Market Share by Region: 2021 VS 2028 Figure 14. Global Hormone Refractory Prostate Cancer Market Share by Players in 2021 Figure 15. Global Top Hormone Refractory Prostate Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormone Refractory Prostate Cancer as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Hormone Refractory Prostate Cancer Revenue in 2021 Figure 17. North America Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. North America Hormone Refractory Prostate Cancer Market Share by Country (2017-2028) Figure 19. United States Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Hormone Refractory Prostate Cancer Market Share by Country (2017-2028) Figure 23. Germany Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. France Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. U.K. Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Italy Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Russia Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Nordic Countries Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Hormone Refractory Prostate Cancer Market Share by Region (2017-2028) Figure 31. China Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Japan Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. South Korea Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Southeast Asia Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. India Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Australia Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Hormone Refractory Prostate Cancer Market Share by Country (2017-2028) Figure 39. Mexico Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Brazil Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Hormone Refractory Prostate Cancer Market Share by Country (2017-2028) Figure 43. Turkey Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Saudi Arabia Hormone Refractory Prostate Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Astellas Inc Revenue Growth Rate in Hormone Refractory Prostate Cancer Business (2017-2022) Figure 46. Sanofi S.A Revenue Growth Rate in Hormone Refractory Prostate Cancer Business (2017-2022) Figure 47. Dendreon Corporation, Bayer AG Revenue Growth Rate in Hormone Refractory Prostate Cancer Business (2017-2022) Figure 48. Johnson & Johnson Revenue Growth Rate in Hormone Refractory Prostate Cancer Business (2017-2022) Figure 49. Bottom-up and Top-down Approaches for This Report Figure 50. Data Triangulation Figure 51. Key Executives Interviewed

Astellas Inc Sanofi S.A Dendreon Corporation, Bayer AG Johnson & Johnson